Search for content, post, videos

Latest news

Sponsored content

Research

In Focus – Entrepreneurs

Business

New Innovation and Design

Clinical Trials

Promising results from NeuroVive
Promising results from NeuroVive

NeuroVive Pharmaceutical and Yungjin Pharm announces that the phase I clinical study in Korea within the companies’ joint project KL1333, an investigational treatment for genetic mitochondrial disorders, including MELAS (Mitochondrial

Drug Development

Careers – On A New Job


View our latest newsletter